Pharmerica Corp (PMC) 24.40 $PMC
Newly Approved Ibrance(R) (Palbociclib) from Pfizer Available Through Onco360
Business Wire - Mon Feb 09, 7:01AM CST
Onco360, one of the nation's largest independent providers of Oncology Pharmacy services, today announced that it has been selected by Pfizer, Inc. ("Pfizer"
as a limited distribution pharmacy network participant for Ibrance (palbociclib), Pfizer's recently approved product for certain breast cancers. The addition of this medication marks another key product win for Onco360, which continues to grow its portfolio of limited distribution products.
PMC: 24.40 (-0.18)
Burt Zweigenhaft to Retire from Onco360
Business Wire - Fri Feb 06, 7:01AM CST
Onco360, one of the nation's largest independent providers of oncology pharmacy services, announced today that Burt Zweigenhaft will be retiring from Onco360 on May 8, 2015. As an early founder, Mr. Zweigenhaft has been a driving force of Onco360 for the past nine years, and has built the Company's reputation as a provider of high quality Oncology Pharmacy services for cancer patients. During his tenure with Onco360, the Company has grown from a local Oncology Pharmacy serving patients in the metropolitan New York area, to a national provider servicing thousands of cancer patients across the United States.
PMC: 24.40 (-0.18)
PharMerica reports March 2
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 9:16AM CST
PMC: 24.40 (-0.18)
Community Bank Shares of Indiana, Inc. Names New Board Member
Business Wire - Wed Feb 04, 7:01AM CST
Community Bank Shares of Indiana, Inc. (NASDAQ: CBIN), the holding company for Your Community Bank and The Scott County State Bank, today has named Phillip J. Keller as a member of its Board of Directors.
PMC: 24.40 (-0.18), BIOS: 6.04 (-0.06), CBIN: 27.23 (+0.08)
PharMerica Corporation Announces Fourth Quarter and Year-End 2014 Earnings Call and Webcast
Business Wire - Wed Feb 04, 7:01AM CST
PharMerica Corporation (NYSE
MC) announced today that it will provide an online webcast of its fourth quarter and year-end 2014 earnings conference call on Monday, March 2, 2015. The Company's results for the fourth quarter and year ended December 31, 2014 will be released before the open of the market on Monday, March 2, 2015.
PMC: 24.40 (-0.18)
Amerita, a Subsidiary of PharMerica, Accelerates Growth with the Acquisition of InfusionRx
Business Wire - Wed Jan 28, 8:03AM CST
Amerita, Inc., a wholly owned subsidiary of PharMerica Corporation (NYSE MC), today announced that it has completed the acquisition of Coastal Pharmaceutical Services Corporation, d/b/a InfusionRx ("InfusionRx" . Financial terms of the transaction were not disclosed.
PMC: 24.40 (-0.18)
PharMerica (PMC) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 23, 7:43AM CST
PharMerica (PMC) Shares March Higher, Can It Continue?
PMC: 24.40 (-0.18)
Is Quest Diagnostics (DGX) Worth Adding to Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 13, 3:50PM CST
On Jan 13, Zacks Investment Research upgraded Quest Diagnostics Inc. (DGX) to a Zacks Rank #1 (Strong Buy).
PMC: 24.40 (-0.18), DGX: 71.68 (+0.03), AMED: 28.62 (+0.16), GTIV: 19.19 (-0.23)
NYSE stocks posting largest volume increases
AP - Thu Jan 08, 5:10PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
PMC: 24.40 (-0.18), FRO: 2.96 (+0.07), CDI: 18.02 (-0.03), CYNI: 3.93 (+0.14), DHT: 6.99 (+0.05), DKS: 53.95 (+0.47), CDR: 7.61 (unch), RPM: 49.79 (-0.11), CRD.B: 9.62 (-0.19), CRD.A: 7.90 (+0.02), TNK: 5.50 (+0.10)
Downtrend Call Working As PharMerica Stock Falls 17.2% (PMC)
Comtex SmarTrend(R) - Wed Jan 07, 5:05PM CST
SmarTrend identified a Downtrend for PharMerica (NYSE MC) on November 11th, 2014 at $25.08. In approximately 2 months, PharMerica has returned 17.22% as of today's recent price of $20.76.
PMC: 24.40 (-0.18)
PharMerica Corporation (PMC) & Hawaiian Holdings Inc. (HA): This Week's Top 2 Value Stocks - Video Blog
Tracey Ryniec - Zacks Investment Research - Tue Jan 06, 2:42PM CST
Tracey Ryniec, Zacks Stock Strategist, discusses two value stocks in healthcare and the airlines in PharMerica Corporation (PMC) and Hawaiian Holdings Inc. (HA).
PMC: 24.40 (-0.18), HA: 18.72 (-0.31)
Quest Diagnostics Hits 52-Week High on Portfolio Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 05, 12:40PM CST
Last month, Quest Diagnostics' (DGX) Simplexa Flu A/B & RSV Direct Kit won U.S. Food & Drug Administration (FDA) clearance for testing eight additional influenza viruses.
PMC: 24.40 (-0.18), AFAM: 30.88 (+0.37), AAC: 29.11 (+0.91), DGX: 71.68 (+0.03)
Onco360 Chosen by Bayer as Limited Distribution Pharmacy Provider
Business Wire - Mon Jan 05, 7:01AM CST
Onco360, one of the nation's largest independent providers of Oncology Pharmacy services, today announced that it has been selected by Bayer AG ("Bayer" as a limited distribution pharmacy network participant for two of its leading oncology medications, Nexavar(R) (sorafenib) and Stivarga(R) (regorafenib). With the addition of these two medications, Onco360's industry-leading oncology medication portfolio now comprises nearly 40 limited distribution products.
PMC: 24.40 (-0.18)
PharMerica Now a Strong Buy, Raised Guidance a Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 8:30AM CST
On Jan 2, 2015, Zacks Investment Research upgraded PharMerica Corp. (PMC) to a Zacks Rank #1 (Strong Buy)
PMC: 24.40 (-0.18), OCR: 76.89 (+0.14), AFAM: 30.88 (+0.37)
17.6% Return Seen to Date on SmarTrend PharMerica Call (PMC)
Comtex SmarTrend(R) - Wed Dec 24, 11:13AM CST
SmarTrend identified a Downtrend for PharMerica (NYSE MC) on November 11th, 2014 at $25.08. In approximately 1 month, PharMerica has returned 17.58% as of today's recent price of $20.67.
PMC: 24.40 (-0.18)
Shares of PMC Down 16.5% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Dec 10, 9:31AM CST
SmarTrend identified a Downtrend for PharMerica (NYSE MC) on November 11th, 2014 at $25.08. In approximately 4 weeks, PharMerica has returned 16.51% as of today's recent price of $20.94.
PMC: 24.40 (-0.18)
Newly Approved Ibrance(R) (Palbociclib) from Pfizer Available Through Onco360
Business Wire - Mon Feb 09, 7:01AM CST
Onco360, one of the nation's largest independent providers of Oncology Pharmacy services, today announced that it has been selected by Pfizer, Inc. ("Pfizer"
as a limited distribution pharmacy network participant for Ibrance (palbociclib), Pfizer's recently approved product for certain breast cancers. The addition of this medication marks another key product win for Onco360, which continues to grow its portfolio of limited distribution products. PMC: 24.40 (-0.18)
Burt Zweigenhaft to Retire from Onco360
Business Wire - Fri Feb 06, 7:01AM CST
Onco360, one of the nation's largest independent providers of oncology pharmacy services, announced today that Burt Zweigenhaft will be retiring from Onco360 on May 8, 2015. As an early founder, Mr. Zweigenhaft has been a driving force of Onco360 for the past nine years, and has built the Company's reputation as a provider of high quality Oncology Pharmacy services for cancer patients. During his tenure with Onco360, the Company has grown from a local Oncology Pharmacy serving patients in the metropolitan New York area, to a national provider servicing thousands of cancer patients across the United States.
PMC: 24.40 (-0.18)
PharMerica reports March 2
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 9:16AM CST
PMC: 24.40 (-0.18)
Community Bank Shares of Indiana, Inc. Names New Board Member
Business Wire - Wed Feb 04, 7:01AM CST
Community Bank Shares of Indiana, Inc. (NASDAQ: CBIN), the holding company for Your Community Bank and The Scott County State Bank, today has named Phillip J. Keller as a member of its Board of Directors.
PMC: 24.40 (-0.18), BIOS: 6.04 (-0.06), CBIN: 27.23 (+0.08)
PharMerica Corporation Announces Fourth Quarter and Year-End 2014 Earnings Call and Webcast
Business Wire - Wed Feb 04, 7:01AM CST
PharMerica Corporation (NYSE
MC) announced today that it will provide an online webcast of its fourth quarter and year-end 2014 earnings conference call on Monday, March 2, 2015. The Company's results for the fourth quarter and year ended December 31, 2014 will be released before the open of the market on Monday, March 2, 2015. PMC: 24.40 (-0.18)
Amerita, a Subsidiary of PharMerica, Accelerates Growth with the Acquisition of InfusionRx
Business Wire - Wed Jan 28, 8:03AM CST
Amerita, Inc., a wholly owned subsidiary of PharMerica Corporation (NYSE
MC), today announced that it has completed the acquisition of Coastal Pharmaceutical Services Corporation, d/b/a InfusionRx ("InfusionRx" . Financial terms of the transaction were not disclosed. PMC: 24.40 (-0.18)
PharMerica (PMC) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 23, 7:43AM CST
PharMerica (PMC) Shares March Higher, Can It Continue?
PMC: 24.40 (-0.18)
Is Quest Diagnostics (DGX) Worth Adding to Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 13, 3:50PM CST
On Jan 13, Zacks Investment Research upgraded Quest Diagnostics Inc. (DGX) to a Zacks Rank #1 (Strong Buy).
PMC: 24.40 (-0.18), DGX: 71.68 (+0.03), AMED: 28.62 (+0.16), GTIV: 19.19 (-0.23)
NYSE stocks posting largest volume increases
AP - Thu Jan 08, 5:10PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
PMC: 24.40 (-0.18), FRO: 2.96 (+0.07), CDI: 18.02 (-0.03), CYNI: 3.93 (+0.14), DHT: 6.99 (+0.05), DKS: 53.95 (+0.47), CDR: 7.61 (unch), RPM: 49.79 (-0.11), CRD.B: 9.62 (-0.19), CRD.A: 7.90 (+0.02), TNK: 5.50 (+0.10)
Downtrend Call Working As PharMerica Stock Falls 17.2% (PMC)
Comtex SmarTrend(R) - Wed Jan 07, 5:05PM CST
SmarTrend identified a Downtrend for PharMerica (NYSE
MC) on November 11th, 2014 at $25.08. In approximately 2 months, PharMerica has returned 17.22% as of today's recent price of $20.76. PMC: 24.40 (-0.18)
PharMerica Corporation (PMC) & Hawaiian Holdings Inc. (HA): This Week's Top 2 Value Stocks - Video Blog
Tracey Ryniec - Zacks Investment Research - Tue Jan 06, 2:42PM CST
Tracey Ryniec, Zacks Stock Strategist, discusses two value stocks in healthcare and the airlines in PharMerica Corporation (PMC) and Hawaiian Holdings Inc. (HA).
PMC: 24.40 (-0.18), HA: 18.72 (-0.31)
Quest Diagnostics Hits 52-Week High on Portfolio Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 05, 12:40PM CST
Last month, Quest Diagnostics' (DGX) Simplexa Flu A/B & RSV Direct Kit won U.S. Food & Drug Administration (FDA) clearance for testing eight additional influenza viruses.
PMC: 24.40 (-0.18), AFAM: 30.88 (+0.37), AAC: 29.11 (+0.91), DGX: 71.68 (+0.03)
Onco360 Chosen by Bayer as Limited Distribution Pharmacy Provider
Business Wire - Mon Jan 05, 7:01AM CST
Onco360, one of the nation's largest independent providers of Oncology Pharmacy services, today announced that it has been selected by Bayer AG ("Bayer"
as a limited distribution pharmacy network participant for two of its leading oncology medications, Nexavar(R) (sorafenib) and Stivarga(R) (regorafenib). With the addition of these two medications, Onco360's industry-leading oncology medication portfolio now comprises nearly 40 limited distribution products. PMC: 24.40 (-0.18)
PharMerica Now a Strong Buy, Raised Guidance a Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 8:30AM CST
On Jan 2, 2015, Zacks Investment Research upgraded PharMerica Corp. (PMC) to a Zacks Rank #1 (Strong Buy)
PMC: 24.40 (-0.18), OCR: 76.89 (+0.14), AFAM: 30.88 (+0.37)
17.6% Return Seen to Date on SmarTrend PharMerica Call (PMC)
Comtex SmarTrend(R) - Wed Dec 24, 11:13AM CST
SmarTrend identified a Downtrend for PharMerica (NYSE
MC) on November 11th, 2014 at $25.08. In approximately 1 month, PharMerica has returned 17.58% as of today's recent price of $20.67. PMC: 24.40 (-0.18)
Shares of PMC Down 16.5% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Dec 10, 9:31AM CST
SmarTrend identified a Downtrend for PharMerica (NYSE
MC) on November 11th, 2014 at $25.08. In approximately 4 weeks, PharMerica has returned 16.51% as of today's recent price of $20.94. PMC: 24.40 (-0.18)
